CALUMET SPECIALTY PRODS PTNR's ticker is CLMT and the CUSIP is 131476103. A total of 116 filers reported holding CALUMET SPECIALTY PRODS PTNR in Q1 2016. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $114,000 | -5.0% | 30,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $120,000 | -11.1% | 30,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $135,000 | -8.2% | 30,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $147,000 | -58.2% | 30,000 | 0.0% | 0.00% | -50.0% |
Q1 2016 | $352,000 | -41.0% | 30,000 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $597,000 | +23.1% | 30,000 | +50.0% | 0.00% | +33.3% |
Q3 2015 | $485,000 | -4.7% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $509,000 | +5.8% | 20,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $481,000 | +7.4% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $448,000 | -18.4% | 20,000 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $549,000 | -13.7% | 20,000 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $636,000 | +105.2% | 20,000 | +66.7% | 0.00% | +100.0% |
Q1 2014 | $310,000 | -0.6% | 12,000 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $312,000 | +27.3% | 12,000 | +33.3% | 0.00% | 0.0% |
Q3 2013 | $245,000 | -19.9% | 9,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $306,000 | – | 9,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wasserstein Debt Opportunities Management, L.P. | 6,891,314 | $110,605,590 | 100.00% |
Knott David M Jr | 4,325,000 | $69,416 | 27.70% |
Adams Asset Advisors, LLC | 5,251,160 | $84,281,118 | 10.99% |
GRIZZLYROCK CAPITAL, LLC | 537,602 | $8,628,512 | 7.16% |
Barnett & Company, Inc. | 281,415 | $4,516,716 | 3.24% |
Bienville Capital Management, LLC | 341,102 | $5,474,687 | 1.31% |
EPACRIA CAPITAL PARTNERS, LLC | 76,037 | $1,220,394 | 0.90% |
Alta Fundamental Advisers LLC | 75,287 | $1,208,356 | 0.38% |
FIFTH LANE CAPITAL, LP | 15,000 | $240,750 | 0.35% |
Gimbal Financial | 27,045 | $458,954 | 0.34% |